12 Feb 2025
Unraveling calcium dysregulation and autoimmunity in immune mediated rippling muscle disease
06 Jan 2025
Antibody internalisation could link clinical phenotypes to subcellular dysfunctions in myositis
29 Nov 2024
Spatial transcriptomics reveal marker of histopathological changes in Duchenne muscular dystrophy mouse models
23 Oct 2024
ABCD3: the first oculopharyngodistal myopathy-related gene in European ancestry
16 Jan 2024
Anti-cN1A antibodies: epiphenomenon or pathogenic?
15 Nov 2023
Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, p
15 Nov 2023
Mass spectrometry-based identification of new anti-Ly and known antisynthetase autoantibodies
20 Jun 2023
Expanding the phenotype: Individuals with variants in the oxidoreductase PYROXD1 present with a myopathy and connective tissue disorder.
09 Mar 2023
Efficient skeletal muscle regeneration is dependent on adipose stromal cells originating from subcutaneous adipose tissue
23 Jan 2023
Trial of Intravenous Immune Globulin in Dermatomyositis
06 Dec 2022
Assessing the Relationship of Patient Reported Outcome Measures With Functional Status in Dysferlinopathy
25 Nov 2022
Depletion of skeletal muscle satellite cells attenuates pathology in muscular dystroph
22 Sep 2022
A novel strategy for the identification of pathogenic intronic/complex genomic variants
25 Aug 2022
Identification of Caveolae-Associated Protein 4 Autoantibodies as a Biomarker of Immune-Mediated Rippling Muscle Disease in Adults
31 Jul 2022
Dystrophin expression comparison in CXMD dog model
21 Jun 2022
Type I interferon in dermatomyositis: Impact on myogenesis and possible autocrine/paracrine effect
19 May 2022
Development of DG9 peptide-conjugated single- and multi-exon skipping therapies for the treatment of Duchenne muscular dystrophy
21 Apr 2022
Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice
14 Mar 2022
Assessing dysferlinopathy patients over three years with a new motor scale
10 Jan 2022
Exploring new therapeutic approaches in FSHD by small molecules modulation of endogenous microRNA
06 Dec 2021
An alternative to corticosteroid for the treatment of Duchenne Muscular Dystrophy
01 Nov 2021
Demonbreun et al identify a novel antibody mediated therapeutic strategy for Duchenne muscular dystrophy based on previous genetic modifier studies.
01 Oct 2021
Severe COVID-19 is associated with post-infectious inflammatory myopathy
02 Sep 2021
Establishing the validity of motor outcome measures in young boys with Duchenne Muscular Dystrophy is critical for the success of future trials
Page 1 of 2, showing 24 records out of 27 total.
